“IRBM is an important Italian biotech centre , which is giving a strategic contribution to the development of one of the vaccines against Covid-19 , a very important reality from the scientific point of view at international level.
Our Global VP of Sales and Marketing, Heidi Kingdon Jones, is attending TIDES Europe: Oligonucleotide and Peptide Therapeutics in Amsterdam. Running from November 12-15, the event is Europe’s primary forum for thought leaders in this growing field to network and drive innovation forward.
Heidi will be available to talk about our extensive expertise in drug discovery in modalities covering small molecule, biologics and peptide therapeutics. If you’d like to learn about our capabilities, which span from hit finding to the synthesis of putative peptide leads through to the delivery of a preclinical candidate, then get in touch to organize a meeting. [Link to contact page on IRBM website]